The risk of breast tumours and lifetime history of oral contraceptive use
Heinemann, L.A.J.; Lewis, M.A.; Kuhlhabich, D.; Braendle, W.; Moehner, S.; G C, E.M.A.N.N. L.A.J.
Geburtshilfe und Frauenheilkunde 62(8): 750-757
2002
ISSN/ISBN: 0016-5751 Document Number: 245237
Document emailed within 1 workday
Related Documents
Rushton, L.; Jones, D.R. 1992: Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use British Journal of Obstetrics and Gynaecology 99(3): 239-246Huzell, L.; Persson, M.; Simonsson, M.; Markkula, A.; Ingvar, C.; Rose, C.; Jernström, H. 2015: History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response Breast Cancer Research and Treatment 149(2): 505-515
Modugno, F.; Ness, R.B.; Allen, G.O.; Schildkraut, J.M.; Davis, F.G.; Goodman, M.T. 2004: Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis American Journal of Obstetrics and Gynecology 191(3): 733-740
Miller, D.R.; Rosenberg, L.; Kaufman, D.W.; Schottenfeld, D.; Stolley, P.D.; Shapiro, S. 1986: Breast cancer risk in relation to early oral contraceptive use Obstetrics and Gynecology 68(6): 863-868
Davidson, B.A.; Moorman, P.G. 2014: Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer Expert Opinion on Drug Safety 13(10): 1375-1382
Bethea, T.N.; Rosenberg, L.; Hong, C-Chen.; Troester, M.A.; Lunetta, K.L.; Bandera, E.V.; Schedin, P.; Kolonel, L.N.; Olshan, A.F.; Ambrosone, C.B.; Palmer, J.R. 2015: A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium Breast cancer research: BCR 17: 22
Freund, R.; Kelsberg, G.; Safranek, S. 2014: Clinical Inquiry: do oral contraceptives put women with a family history of breast cancer at increased risk? Journal of Family Practice 63(9): 540; 549
Freund, R.; Kelsberg, G.; Safranek, S. 2014: Clinical Inquiry: do oral contraceptives put women with a family history of breast cancer at increased risk? Journal of Family Practice 63(9): 540; 549
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2012: Relationship Between Use of Different Oral Contraceptive Formulations and Breast Cancer Risk Among Young Women Cancer Epidemiology Biomarkers and Prevention 21(3): 566-566
Hemminki, E.; Luostarinen, T.; Pukkala, E.; Apter, D.; Hakulinen, T. 2002: Oral contraceptive use before first birth and risk of breast cancer: a case control study Bmc Women's Health 2(1): 9
Weinstein, A.L.; Mahoney, M.C.; Nasca, P.C.; Leske, M.C.; Varma, A.O. 1991: Breast cancer risk and oral contraceptive use: results from a large case-control study Epidemiology 2(5): 353-358
Bui, K.T.; Wakefield, C.E.; Kasparian, N.A.; Tyler, J.; Abbott, J.; Tucker, K. 2013: Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes Psycho-Oncology 22(1): 228-232
Gierisch, J.M.; Coeytaux, R.R.; Urrutia, R.P.; Havrilesky, L.J.; Moorman, P.G.; Lowery, W.J.; Dinan, M.; McBroom, A.J.; Hasselblad, V.; Sanders, G.D.; Myers, E.R. 2013: Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 22(11): 1931-1943
Walker, G.R.; Schlesselman, J.J.; Ness, R.B. 2002: Family history of cancer, oral contraceptive use, and ovarian cancer risk American Journal of Obstetrics and Gynecology 186(1): 8-14
Francis Likis 2005: Do Higher Weight And BMI Increase The Risk Of Oral Contraceptive Failure?: Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 2005;105:4652 Journal of Midwifery and Women's Health 50(3): 251-251
1989: Oral contraceptive use and breast cancer risk in young women. UK National Case-Control Study Group Lancet 1(8645): 973-982
Xu, W-Hong.; Shu, X-Ou.; Long, J.; Lu, W.; Cai, Q.; Zheng, Y.; Xiang, Y-Bing.; Dai, Q.; Zhao, G-Ming.; Gu, K.; Bao, P-Ping.; Gao, Y-Tang.; Zheng, W. 2011: Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women American Journal of Epidemiology 173(8): 923-931
Grant, E.C.G. 2017: Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy American Journal of Obstetrics and Gynecology 217(2): 232-233
Ferris, J.S.; Daly, M.B.; Buys, S.S.; Genkinger, J.M.; Liao, Y.; Terry, M.B. 2014: Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry British Journal of Cancer 110(4): 1074-1080
Bond, S. 2014: Large prospective study finds no association between oral contraceptive use and breast cancer but increased risk for cervical cancer Journal of Midwifery and Women's Health 59(2): 218-219